Vaccines for preventing influenza in healthy adults (Q24234114)

2

0 references

Tom Jefferson

1

Tom Jefferson

0 references

Alessandro Rivetti

3

Alessandro Rivetti

0 references

Lubna A. Al-Ansary

5

Lubna A Al-Ansary

0 references

Eliana Ferroni

6

Eliana Ferroni

0 references

author name string

Ghada A Bawazeer

Cochrane Database of Systematic Reviews

4

0 references

publication date

7 July 2010

0 references

published in

0 references

cites work

Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Efficacy of live attenuated influenza A/Scotland/74 (H3N2) virus vaccine against challenge with influenza A/Victoria/3/75 (H3N2) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Reactogenicity and Immunogenicity of Parenteral Monovalent Influenza A/Victoria/3/75 (H3N2) Virus Vaccine in Healthy Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

WRL 105 strain live attenuated influenza vaccine; comparison of one and two dose schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

An assessment of oil adjuvant and aqueous influenza vaccines: I. Reactions to the vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

An Attenuated Influenza Virus Vaccine: Reactogenicity, Transmissibility, Immunogenicity, and Protective Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Is there a relationship between influenza vaccinations and risk of melanoma? A population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Clinical and serologic effects of live attenuated serum inhibitor-resistant influenza B vaccine in seronegative adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Evaluation of an attenuated, cold-recombinant influenza B virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

The Effectiveness of Vaccination against Influenza in Healthy, Working Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Studies in man with a cold-recombinant live influenza B virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Influenza vaccination with live-attenuated and inactivated virus-vaccines during an outbreak of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Field trial of live attenuated influenza A/B ("Alice"/R-75) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Influenza Immunization: Field Trial on a University Campus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Immunization against influenza among working adults: the Philippines experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Effectiveness of an influenza vaccine used in Poland in the 1998-1999 influenza season

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Comparative Study of Reactogenicity and Immunogenicity of Influenza A/New Jersey/8/76 (Hsw1N1) Virus Vaccines in Normal Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Clinical Trials of Monovalent Influenza A/New Jersey/76 Virus Vaccines in Adults: Reactogenicity, Antibody Response, and Antibody Persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Bell's palsy associated with influenza vaccination: two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Immunogenicity and Reactogenicity of Influenza A/New Jersey/76 Virus Vaccines in Normal Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A clinical and serologic comparison of standard and purified bivalent inactivated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Influenza B Virus Vaccines in Children and Adults: Adverse Reactions, Immune Response, and Observations in the Field

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Guillain-Barré syndrome following influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers: A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community: A report to the Medical Research Council Committee on Influenza and other respiratory virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Influenza at Christ's Hospital: March, 1974.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Assessment of effectiveness of Vaxigrip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity and respiratory morbidity over the winter of 1997-98.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Prevention of influenza in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Comparative trials of live attenuated and detergent split influenza virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A controlled trial of inactivated monovalent influenza A vaccines in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Trivalent intranasal influenza vaccine, live

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Could influenza vaccination prevent myocardial infarction, stroke and sudden cardiac death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Recombinant WRL 105 strain live attenuated influenza vaccine. Immunogenicity, reactivity, and transmissibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Studies of Inactivated Influenza Virus Vaccines in Hospital Employees: Reactogenicity and Absenteeism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Side Effects Associated With Influenza Vaccination in Healthy Working Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Live attenuated influenza virus vaccines: new options for the prevention of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Protection from natural infection after live influenza virus immunization in an open population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A New Subunit Influenza Vaccine: Acceptability Compared with Standard Vaccines and Effect of Dose on Antigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Serological response to whole, split and subunit influenza vaccines of persons with and without immunological experience towards influenza A/U.S.S.R. 90/77 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Guillain-Barr� syndrome: Its epidemiology and associations with influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

The response to inactivated influenza A (H3N2) vaccines: the development and effect of antibodies to the surface antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Antigenicity and Reactivity of Influenza A/New Jersey/8/76 Virus Vaccines in Military Volunteers at Fort Ord, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Clinical Trials with Alice Strain, Live, Attenuated, Serum Inhibitor-Resistant Intranasal Influenza A Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

A clinical trial with Alice/R-75 strain, live attenuated serum inhibitor-resistant intranasal bivalent influenza A/B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Antibody response and reactions to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Vaccination against Hong Kong influenza in Britain, 1968–9: A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Effectiveness of influenza vaccine in health care professionals: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Effectiveness and economical impact of vaccination against influenza among a working population in Moscow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Economic evaluations of influenza vaccination in healthy working-age adults. Employer and society perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Inactivated influenza vaccines: methods, policies, and politics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Influenza: diagnosis, management, and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Vaccines for preventing influenza in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Vaccines for preventing influenza in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Preventing influenza in healthy adults: the evolving story

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Immunogenicity of influenza A/USSR (H1N1) subunit vaccine in unprimed young adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Do hospital employees benefit from the influenza vaccine? A placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Influenza vaccine efficacy in young, healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Influenza vaccination and the risk of primary cardiac arrest

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980-1983

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Evaluation of monovalent and polyvalent influenza vaccines during an epidemic of type A2 and B influenza

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Asthma and vaccination history in a young adult cohort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

National surveillance for Guillain-Barré syndrome: January 1978-March 1979

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Clinical trial of a subunit influenza vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

Pneumococcal Vaccine: Dose, Revaccination, and Coadministration with Influenza Vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB4

7 January 2021

10.1002/14651858.CD001269.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20614424

1 reference

Consolidated OpenCitations Corpus – April 2017